Zeo ScientifiX, Inc.
corporate_fare Company Profile
Zeo ScientifiX, Inc. (OTC:ZEOX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ZEOX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for ZEOX spans 8-K, 10-KT, SCHEDULE 13D/A, 10-Q.
Recent high-impact activity:
- ZEO Signs Definitive Deal With Pluri; Pluri to Own 50% of ZEO at Closing
- Zeo ScientifiX Posts 89% Revenue Growth, but Auditor Raises Going Concern Doubt
- Wendy Grey and Greyt Ventures tighten grip on Zeo ScientifiX with 23.88% stake and 49.38% voting power
- Zeo ScientifiX Q2 Revenue Jumps 125% to $2.58M, Net Loss Narrows Significantly
- Zeo ScientifiX Reports Strong Revenue Growth, Reduced Loss, and $2.05M Capital Raise Amidst Dilution and Going Concern
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,193 shares in ZEOX as of the October 30, 2026 settlement, a 1079.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 19.6% of ZEOX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.